Document:

EX-10.19

 Exhibit 10.19 

SONENDO, INC. 
 EXECUTIVE
SEVERANCE PLAN 
 Sonendo, Inc., a Delaware corporation (the “Company”), has adopted this Sonendo, Inc. Executive
Severance Plan, including the attached Exhibits (the “Plan”), for the benefit of Participants (as defined below) on the terms and conditions hereinafter stated. The Plan, as set forth herein, is intended to provide severance
protections to a select group of management or highly compensated employees (within the meaning of ERISA (as defined below)) in connection with qualifying terminations of employment. 

1. Defined Terms. Capitalized terms used but not otherwise defined herein shall have the meanings indicated below: 

1.1 “Base Salary” means the Participant’s annual base salary rate in effect immediately prior to a Qualifying
Termination, disregarding any reduction which gives rise to Good Reason. 
 1.2 “Board” means the Board of Directors
of the Company. 
 1.3 “Cash Salary Severance” means the portion of a Participant’s Cash Severance that is based on the
Participant’s Base Salary determined in accordance with Exhibit A or Exhibit B attached hereto, as applicable. 

1.4 “Cash Severance” means the Cash Salary Severance and, with respect to a CIC Termination, the Participant’s Target
Bonus, determined in accordance with Exhibit A or Exhibit B attached hereto, as applicable. For the avoidance of doubt, Cash Severance shall not include a Participant’s
Pro-Rata Target Bonus, if any. 
 1.5 “Cause” means, except as may otherwise be
provided in a Participant’s employment agreement to the extent such agreement is in effect at the relevant time, any of the following events: 

(a) the Participant’s material failure substantially to perform his or her duties and responsibilities to the Company (other than any such
failure resulting from the Participant’s incapacity due to physical or mental illness or any such actual or anticipated failure after his or her issuance of a notice of termination for Good Reason) or carry out or comply with a lawful and
reasonable directive of the Company; 
 (b) the Participant’s failure or refusal to comply in any material respect with the lawful
directives of the Company or with any Company policy; 
 (c) the Participant’s commission of, including any entry by the Participant of
a guilty or no contest plea to, any felony under any state, federal or foreign law or any crime involving moral turpitude, or the Participant’s commission of unlawful harassment or discrimination; 

(d) the Participant’s commission of any act of fraud, embezzlement, dishonesty or any other unlawful act against the Company or involving
its property or assets; 
 (e) the Participant’s engagement in unprofessional, unethical or other intentional acts that the Board
reasonably believes discredit the Company or are detrimental to the reputation, character or standing of the Company; 
 (f) breach by the
Participant of his or her fiduciary duty to the Company; 

  
 1 

 (g) the Participant’s willful breach of any of his or her obligations under any written
agreement or covenant with the Company, including, without limitation, the Mutual Non-Disclosure Agreement to be entered into between the Participant and the Company; or 

(h) the Participant’s breach of any statutory duty, fiduciary duty or any other obligation owed by the Participant to the Company. 

1.6 “Change in Control” shall have the meaning set forth in the Company’s 2021 Incentive Award Plan, as may be amended
from time to time. 
 1.7 “CIC Protection Period” means the 12 month period beginning on the date on which a Change
in Control is consummated and ending on and including the one-year anniversary of the date of a Change in Control. 

1.8 “CIC Termination” means a Qualifying Termination which occurs during the CIC Protection Period. 

1.9 “Claimant” shall have the meaning set forth in Section 11.1 hereof. 

1.10 “COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985. 

1.11 “COBRA Period” means the number of months used to calculate the COBRA Subsidy, determined in accordance with
Exhibit A or Exhibit B attached hereto, as applicable. 
 1.12 “COBRA Subsidy” shall have
the meaning set forth in Section 4.2(b) hereof. 
 1.13 “Code” means the Internal Revenue Code of 1986, as amended from
time to time, or any successor thereto. 
 1.14 “Committee” means the Compensation Committee of the Board, or such other
committee as may be appointed by the Board to administer the Plan. 
 1.15 “Date of Termination” means the effective date of
the termination of the Participant’s employment. 
 1.16 “Effective Date” shall have the meaning set forth in
Section 2 hereof. 
 1.17 “Employee” means an individual who is an employee (within the meaning of Code
Section 3401(c)) of the Company or any of its subsidiaries. 
 1.18 “Equity Award” means a Company equity award that
vests solely based on the passage of time granted under any equity-based award plan of the Company, including, but not limited to, the Company’s 2021 Incentive Award Plan, as may be amended from time to time. 

1.19 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended, and the regulations promulgated
thereunder. 
 1.20 “Excise Tax” shall have the meaning set forth in Section 7.1 hereof. 

  
 2 

 1.21 “Good Reason” means the occurrence of any one or more of the following
events without the Participant’s prior written consent, unless the Company fully corrects the circumstances constituting Good Reason (provided such circumstances are capable of correction) as provided below: 

(a) a material diminution in the Participant’s duties, title or responsibilities, excluding for this purpose any isolated, insubstantial
or inadvertent actions not taken in bad faith and which are remedied by the Company promptly after receipt of notice thereof given by the Participant; 

(b) a material change in the geographic location at which the Participant performs his or her principal duties for the Company to a new
location that is more than 35 miles from the location at which the Participant performs his or her principal duties for the Company as of the date on which the Participant first becomes a Participant in the Plan; or 

(c) any material reduction in the Participant’s Base Salary (other than a general reduction that affects all similarly situated executives
in substantially the same proportions). 
 Notwithstanding the foregoing, the Participant will not be deemed to have resigned for Good Reason unless
(1) the Participant provides written notice to the Company setting forth in reasonable detail the facts and circumstances claimed by the Participant to constitute Good Reason within 90 days after the date of the occurrence of any event that the
Participant knows or should reasonably have known to constitute Good Reason; (2) the Company fails to cure such acts or omissions within 30 days following its receipt of such notice; and (3) the effective date of the Participant’s
termination for Good Reason occurs no later than 60 days after the expiration of the Company’s cure period. With respect to the foregoing definition, the term “Company” will be interpreted to include any subsidiary, parent, affiliate,
or any successor thereto, if appropriate. 
 1.22 “Independent Advisors” shall have the meaning set forth in
Section 7.2 hereof. 
 1.23 “Participant” means each Employee who is selected by the Administrator to participate in
the Plan and is provided with (and, if applicable, countersigns) a Participation Notice in accordance with the Plan, other than any Employee who, at the time of his or her termination of employment, is covered by a plan or agreement with the Company
or a subsidiary that provides for cash severance or termination benefits that explicitly supersedes and/or replaces the payments and benefits provided under this Plan. For the avoidance of doubt, retention bonus payments, change in control bonus
payments and other similar cash payments shall not constitute “cash severance” for purposes of this definition. 
 1.24
“Participation Notice” shall have the meaning set forth in Section 2 hereof. 
 1.25 “Pro-Rata Target Bonus” means the Participant’s Target Bonus for the year of termination, determined by multiplying the Participant’s Target Bonus amount by the quotient obtained by dividing
(i) the number of days during the year that the Participant was employed through the Qualifying Termination date by (ii) the total number of days in the year. 

1.26 “Qualifying Termination” means a termination of the Participant’s employment with the Company or a subsidiary
thereof, as applicable, by the Company or a subsidiary, as applicable, without Cause, or by the Participant for Good Reason. A Qualifying Termination shall not include a termination due to the Participant’s death or disability. 

1.27 “Release” shall have the meaning set forth in Section 4.4 hereof. 

  
 3 

 1.28 “Severance Benefits” means the severance payments and benefits to
which a Participant may become entitled pursuant to Section 4 of the Plan and Exhibit A or Exhibit B, as applicable and each as attached hereto. 

1.29 “Severance Classification” means, with respect to any Participant, his or her designation as a “Tier 1” or
“Tier 2” participant in the Plan. 
 1.30 “Target Bonus” means the Participant’s annual target cash
performance bonus, if any, for the year in which the Date of Termination occurs. 
 1.31 “Total Payments” shall have the
meaning set forth in Section 7.1 hereof. 
 2. Effectiveness of the Plan; Notification. The Plan shall become effective on
[_____],2021 (the “Effective Date”). The Administrator shall, pursuant to a written notice to an Employee (a “Participation Notice”), notify each Participant that such Participant has been selected to participate in
the Plan and of such Participant’s Severance Classification. 
 3. Administration. Subject to Section 13.3 hereof, the Plan
shall be interpreted, administered and operated by the Committee (the “Administrator”), which shall have complete authority, subject to the express provisions of the Plan, to interpret the Plan, to prescribe, amend and rescind rules
and regulations relating to the Plan, and to make all other determinations necessary or advisable for the administration of the Plan. The Administrator may delegate any of its duties hereunder to a subcommittee, or to such person or persons from
time to time as it may designate other than to any Participant in the Plan, and the Administrator may delegate (other than to any Participant in the Plan) its duty to provide a Participation Notice to a Participant in the Plan. All decisions,
interpretations and other actions of the Administrator (including with respect to whether a Qualifying Termination has occurred) shall be final, conclusive and binding on all parties who have an interest in the Plan. 

4. Severance Benefits.  

4.1 Eligibility. Each Employee who qualifies as a Participant and who experiences a Qualifying Termination is eligible to receive
Severance Benefits under the Plan. 
 4.2 Qualifying Termination Payment. In the event that a Participant experiences a
Qualifying Termination (other than a CIC Termination), then, subject to the Participant’s execution and, to the extent applicable, non-revocation of a Release in accordance with Section 4.4 hereof,
and subject to any additional requirements specified in the Plan, the Company shall pay or provide to the Participant the following Severance Benefits: 

(a) Cash Salary Severance Payment. The Company shall pay to the Participant an amount equal to the Cash
Salary Severance determined in accordance with Exhibit A attached hereto. Subject to Section 6.2 hereof, the Cash Salary Severance (as set forth on Exhibit A) shall be paid in a lump sum on
the 60th day following the Date of Termination. 
 (b) COBRA.
Subject to the requirements of the Code, if the Participant properly elects healthcare continuation coverage under the Company’s group health plans pursuant to COBRA, to the extent that the Participant is eligible to do so, then the Company
shall directly pay or, at its election, reimburse the Participant for the difference between the monthly COBRA premiums paid by the Participant for himself or herself and his or her covered dependents and the monthly premium amount paid by similarly
situated active executives (in an amount determined based on the same 

  
 4 

 
benefit levels as would have applied if the Participant’s employment had not been terminated based on the Participant’s elections in effect on the Date of Termination) until the earlier
of the end of the month during which the Participant’s COBRA Period, determined in accordance with Exhibit A attached hereto, ends or the date the Participant becomes eligible for healthcare coverage under a subsequent
employer’s health plan (the “COBRA Subsidy”). Notwithstanding the foregoing, (i) if any plan pursuant to which such benefits are provided is not, or ceases prior to the expiration of the period of continuation coverage to
be, exempt from the application of Code Section 409A under Treasury Regulation Section 1.409A-1(a)(5), or (ii) the Company is otherwise unable to continue to cover the Participant under its
group health plans without penalty under applicable law (including without limitation, Section 2716 of the Public Health Service Act or the Patient Protection and Affordable Care Act), then, in either case, an amount equal to each remaining
Company reimbursement shall thereafter be paid to the Participant in substantially equal monthly installments over the COBRA Period (or the remaining portion thereof). 

(c) Pro-Rata Target Bonus. If the Participant is eligible to receive a Pro-Rata Target Bonus in accordance with Exhibit A attached hereto, the Company shall pay or provide to the Participant, as applicable, the Participant’s
Pro-Rata Target Bonus, payable in a single lump sum on the 60th day following the Date of Termination in accordance with the Company’s normal payroll
practice. 
 4.3 CIC Termination Payment. In the event that a Participant experiences a CIC Termination, then, subject to the
Participant’s execution and, to the extent applicable, non-revocation of a Release in accordance with Section 4.4 hereof, and subject to any additional requirements specified in the Plan: 

(a) Cash Severance. The Company shall pay or provide to the Participant, as applicable, an amount equal to the Cash Severance determined
in accordance with Exhibit B attached hereto. Subject to Section 6.2 hereof, the Cash Severance (as set forth on Exhibit B) shall be paid in a lump sum on the 60th day following
the Date of Termination. 
 (b) COBRA. The Company shall provide to the Participant the COBRA Subsidy set forth in Section 4.2(b)
hereof; provided, however, that the COBRA Period shall be determined in accordance with Exhibit B attached hereto (instead of in accordance with Exhibit A). 

(c) Equity Awards. Each outstanding Equity Award held by the Participant as of his or her Date of Termination shall vest as specified in
Exhibit B, and, as applicable, become exercisable upon the later of the effectiveness of the Release and as of immediately prior to the consummation of a Change in Control. 

4.4 Release. Notwithstanding anything herein to the contrary, no Participant shall be eligible or entitled to receive or retain any
Severance Benefits under the Plan unless he or she executes a general release of claims substantially in the form attached hereto as Exhibit C (the “Release”) within 21 days (or 45 days if necessary to
comply with applicable law) after the Date of Termination and, if he or she is entitled to a seven day post-signing revocation period under applicable law, does not revoke such Release during such seven day period. 

5. Limitations. Notwithstanding any provision of the Plan to the contrary, if a Participant’s status as an Employee is terminated
for any reason other than due to a Qualifying Termination, the Participant shall not be entitled to receive any Severance Benefits under the Plan, and the Company shall not have any obligation to such Participant under the Plan. 

  
 5 

 6. Section 409A. 

6.1 General. To the extent applicable, the Plan shall be interpreted and applied consistent and in accordance with Code
Section 409A and Department of Treasury regulations and other interpretive guidance issued thereunder. Notwithstanding any provision of the Plan to the contrary, to the extent that the Administrator determines that any payments or benefits
under the Plan may not be either compliant with or exempt from Code Section 409A and related Department of Treasury guidance, the Administrator may in its sole discretion adopt such amendments to the Plan or take such other actions that the
Administrator determines are necessary or appropriate to (a) exempt the compensation and benefits payable under the Plan from Code Section 409A and/or preserve the intended tax treatment of such compensation and benefits, or
(b) comply with the requirements of Code Section 409A and related Department of Treasury guidance; provided, however, that this Section 6.1 shall not create any obligation on the part of the Administrator to adopt any
such amendment or take any other action, nor shall the Company have any liability for failing to do so. 
 6.2 Potential Six-Month Delay. Notwithstanding anything to the contrary in the Plan, no amounts shall be paid to any Participant under the Plan during the six-month period following
such Participant’s “separation from service” (within the meaning of Code Section 409A(a)(2)(A)(i) and Treasury Regulation Section 1.409A-1(h)) to the extent that the Administrator
determines that paying such amounts at the time or times indicated in the Plan would result in a prohibited distribution under Code Section 409A(a)(2)(B)(i). If the payment of any such amounts is delayed as a result of the previous sentence,
then on the first business day following the end of such six-month period (or such earlier date upon which such amount can be paid under Code Section 409A without resulting in a prohibited distribution,
including as a result of the Participant’s death), the Participant shall receive payment of a lump-sum amount equal to the cumulative amount that would have otherwise been payable to the Participant
during such six-month period without interest thereon. 
 6.3 Separation from Service. A
termination of employment shall not be deemed to have occurred for purposes of any provision of the Plan providing for the payment of any amounts or benefits that constitute “nonqualified deferred compensation” under Code Section 409A
upon or following a termination of employment unless such termination is also a “separation from service” within the meaning of Code Section 409A and, for purposes of any such provision of the Plan, references to a
“termination,” “termination of employment” or like terms shall mean “separation from service”. 
 6.4
Reimbursements. To the extent that any payments or reimbursements provided to a Participant under the Plan are deemed to constitute compensation to the Participant to which Treasury Regulation
Section 1.409A-3(i)(1)(iv) would apply, such amounts shall be paid or reimbursed reasonably promptly, but not later than December 31st of the year following the year in which the expense was
incurred. The amount of any such payments eligible for reimbursement in one year shall not affect the payments or expenses that are eligible for payment or reimbursement in any other taxable year, and the Participant’s right to such payments or
reimbursement of any such expenses shall not be subject to liquidation or exchange for any other benefit. 
 6.5 Installments. For
purposes of applying the provisions of Code Section 409A to the Plan, each separately identified amount to which a Participant is entitled under the Plan shall be treated as a separate payment. In addition, to the extent permissible under Code
Section 409A, the right to receive any installment payments under the Plan shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and
distinct payment as permitted under Treasury Regulation Section 1.409A-2(b)(2)(iii). Whenever a payment under the Plan specifies a payment period with reference to a number of days, the actual date of
payment within the specified period shall be within the sole discretion of the Company. 

  
 6 

 7. Limitation on Payments. 

7.1 Best Pay Cap. Notwithstanding any other provision of the Plan, in the event that any payment or benefit received or to be received
by a Participant (including any payment or benefit received in connection with a termination of the Participant’s employment, whether pursuant to the terms of the Plan or any other plan, arrangement or agreement) (all such payments and
benefits, including the Severance Benefits, being hereinafter referred to as the “Total Payments”) would be subject (in whole or part), to the excise tax imposed under Code Section 4999 (the “Excise Tax”),
then, after taking into account any reduction in the Total Payments provided by reason of Code Section 280G in such other plan, arrangement or agreement, the Cash Severance benefits under the Plan shall first be reduced, and any non-cash severance payments shall thereafter be reduced, to the extent necessary so that no portion of the Total Payments is subject to the Excise Tax but only if (a) the net amount of such Total Payments, as
so reduced (and after subtracting the net amount of federal, state and local income taxes on such reduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such reduced Total
Payments) is greater than or equal to (b) the net amount of such Total Payments without such reduction (but after subtracting the net amount of federal, state and local income taxes on such Total Payments and the amount of Excise Tax to which
the Participant would be subject in respect of such unreduced Total Payments and after taking into account the phase out of itemized deductions and personal exemptions attributable to such unreduced Total Payments). 

7.2 Certain Exclusions. For purposes of determining whether and the extent to which the Total Payments will be subject to the Excise
Tax, (a) no portion of the Total Payments, the receipt or retention of which the Participant has waived at such time and in such manner so as not to constitute a “payment” within the meaning of Code Section 280G(b), will be taken
into account; (b) no portion of the Total Payments will be taken into account which, in the written opinion of an independent, nationally recognized accounting firm (the “Independent Advisors”) selected by the Company, does not
constitute a “parachute payment” within the meaning of Code Section 280G(b)(2) (including by reason of Code Section 280G(b)(4)(A)) and, in calculating the Excise Tax, no portion of such Total Payments will be taken into account
which, in the opinion of Independent Advisors, constitutes reasonable compensation for services actually rendered, within the meaning of Code Section 280G(b)(4)(B), in excess of the “base amount” (as defined in Code
Section 280G(b)(3)) allocable to such reasonable compensation; and (c) the value of any non-cash benefit or any deferred payment or benefit included in the Total Payments shall be determined by the
Independent Advisors in accordance with the principles of Code Sections 280G(d)(3) and (4). 
 8. No Mitigation. No Participant
shall be required to seek other employment or attempt in any way to reduce or mitigate any Severance Benefits payable under the Plan and the amount of any such Severance Benefits shall not be reduced by any other compensation paid or provided to any
Participant following such Participant’s termination of employment. 
 9. Successors. 

9.1 Company Successors. The Plan shall inure to the benefit of and shall be binding upon the Company and its successors and assigns. Any
successor (whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume and agree to perform the obligations of the
Company under the Plan. 

  
 7 

 9.2 Participant Successors. The Plan shall inure to the benefit of and be enforceable
by each Participant’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees, legatees or other beneficiaries. If a Participant dies while any amount remains payable to such Participant
hereunder, all such amounts shall be paid in accordance with the terms of the Plan to the executors, personal representatives or administrators of such Participant’s estate. 

10. Notices. All communications relating to matters arising under the Plan shall be in writing and shall be deemed to have been duly
given when hand delivered, faxed, emailed or mailed by reputable overnight carrier or United States certified mail, return receipt requested, addressed, if to a Participant, to the address or email address on file with the Company or to such other
address or email address as the Participant may have furnished to the other in writing in accordance herewith and, if to the Company, to such address or email address as may be specified from time to time by the Administrator, except that notice of
change of address shall be effective only upon actual receipt. 
 11. Claims Procedure; Arbitration. 

11.1 Claims. Generally, Participants are not required to present a formal claim in order to receive benefits under the Plan. If,
however, any person (the “Claimant”) believes that benefits are being denied improperly, that the Plan is not being operated properly, that fiduciaries of the Plan have breached their duties, or that the Claimant’s legal rights
are being violated with respect to the Plan, the Claimant must file a formal claim, in writing, with the Administrator. This requirement applies to all claims that any Claimant has with respect to the Plan, including claims against fiduciaries and
former fiduciaries, except to the extent the Administrator determines, in its sole discretion that it does not have the power to grant all relief reasonably being sought by the Claimant. A formal claim must be filed within 90 days after the date the
Claimant first knew or should have known of the facts on which the claim is based, unless the Administrator consents otherwise in writing. The Administrator shall provide a Claimant, on request, with a copy of the claims procedures established under
Section 11.2 hereof. 
 11.2 Claims Procedure. The Administrator has adopted procedures for considering claims (which are set
forth in Exhibit D attached hereto), which it may amend or modify from time to time, as it sees fit. These procedures shall comply with all applicable legal requirements. These procedures may provide that final and binding
arbitration shall be the ultimate means of contesting a denied claim (even if the Administrator or its delegates have failed to follow the prescribed procedures with respect to the claim). The right to receive benefits under the Plan is contingent
on a Claimant using the prescribed claims and arbitration procedures to resolve any claim. 
 12. Covenants. 

12.1 Restrictive Covenants. A Participant’s right to receive and/or retain the Severance Benefits payable under this Plan is
conditioned upon and subject to the Participant’s continued compliance with any restrictive covenants (e.g., confidentiality, non-solicitation, non-disparagement)
contained in any other written agreement between the Participant and the Company, as in effect on the date of the Participant’s Qualifying Termination. 

12.2 Return of Property. A Participant’s right to receive and/or retain the Severance Benefits payable under the Plan is
conditioned upon the Participant’s return to the Company of all Company documents (and all copies thereof) and other Company property (in each case, whether physical, electronic or otherwise) in the Participant’s possession or control.

  
 8 

 13. Miscellaneous. 

13.1 Entire Plan; Relation to Other Agreements. The Plan, together with any Participation Notice issued in connection with the Plan,
contains the entire understanding of the parties relating to the subject matter hereof and supersedes any prior agreement, arrangement and understanding between any Participant, on the one hand, and the Company and/or any subsidiary, on the other
hand, with respect to the subject matter hereof. Severance payable under the Plan is not intended to duplicate any other severance benefits payable to a Participant by the Company. By participating in the Plan and accepting the Severance Benefits
hereunder, the Participant acknowledges and agrees that any prior agreement, arrangement and understanding between any Participant, on the one hand, and the Company and/or any subsidiary, on the other hand, with respect to the subject matter hereof
is hereby revoked and ineffective with respect to the Participant (including with respect to any severance arrangement contained in an effective employment agreement, employment letter agreement by and between the Participant and the Company (and/or
any subsidiary)). 
 13.2 No Right to Continued Service. Nothing contained in the Plan shall (a) confer upon any Participant any
right to continue as an employee of the Company or any subsidiary, (b) constitute any contract of employment or agreement to continue employment for any particular period, or (c) interfere in any way with the right of the Company to
terminate a service relationship with any Participant, with or without Cause. 
 13.3 Termination and Amendment of Plan. The Plan may
not be amended, modified, suspended or terminated except with the express written consent of each Participant who would be adversely affected by any such amendment, modification, suspension or termination. 

13.4 Survival. Section 7 (Limitation on Payments), Section 11 (Claims Procedure; Arbitration) and Section 12 (Covenants)
hereof shall survive the termination or expiration of the Plan and shall continue in effect. 
 13.5 Severance Benefit Obligations.
Notwithstanding anything contained herein, Severance Benefits paid or provided under the Plan may be paid or provided by the Company or any subsidiary employer, as applicable. 

13.6 Withholding. The Company shall have the authority and the right to deduct and withhold an amount sufficient to satisfy federal,
state, local and foreign taxes required by law to be withheld with respect to any Severance Benefits payable under the Plan. 
 13.7
Benefits Not Assignable. Except as otherwise provided herein or by law, no right or interest of any Participant under the Plan shall be assignable or transferable, in whole or in part, either directly or by operation of law or otherwise,
including without limitation by execution, levy, garnishment, attachment, pledge or in any manner; no attempted assignment or transfer thereof shall be effective; and no right or interest of any Participant under the Plan shall be liable for, or
subject to, any obligation or liability of such Participant. When a payment is due under the Plan to a Participant who is unable to care for his or her affairs, payment may be made directly to his or her legal guardian or personal representative.

 13.8 Applicable Law. The Plan is intended to be an unfunded “top hat” pension plan within the meaning of U.S. Department
of Labor Regulation Section 2520.104-23 and shall be interpreted, administered, and enforced as such in accordance with ERISA. To the extent that state law is applicable, the statutes and common law of
the State of Delaware, excluding any that mandate the use of another jurisdiction’s laws, will apply. 

  
 9 

 13.9 Validity. The invalidity or unenforceability of any provision of the Plan shall
not affect the validity or enforceability of any other provision of the Plan, which shall remain in full force and effect. 
 13.10
Captions. The captions contained in the Plan are for convenience only and shall have no bearing on the meaning, construction or interpretation of the Plan’s provisions. 

13.11 Expenses. The expenses of administering the Plan shall be borne by the Company or its successor, as applicable. 

13.12 Unfunded Plan. The Plan shall be maintained in a manner to be considered “unfunded” for purposes of ERISA. The Company
shall be required to make payments only as benefits become due and payable. No person shall have any right, other than the right of an unsecured general creditor against the Company, with respect to the benefits payable hereunder, or which may be
payable hereunder, to any Participant, surviving spouse or beneficiary hereunder. If the Company, acting in its sole discretion, establishes a reserve or other fund associated with the Plan, no person shall have any right to or interest in any
specific amount or asset of such reserve or fund by reason of amounts which may be payable to such person under the Plan, nor shall such person have any right to receive any payment under the Plan except as and to the extent expressly provided in
the Plan. The assets in any such reserve or fund shall be part of the general assets of the Company, subject to the control of the Company. 

* * * * * 

  
 10 

 EXHIBIT A 

CALCULATION OF QUALIFYING TERMINATION SEVERANCE AMOUNTS 
  

							
	 Severance Classification
	  	 Cash Salary Severance
	  	 Pro-Rata Target
Bonus
	  	 COBRA

Period (1)

	Tier 1	  	12 months Base Salary	  	Pro-Rata Target Bonus	  	12 months
	Tier 2	  	6 months Base Salary	  	None	  	6 months

  

	(1)	 COBRA Period begins on the first day of the calendar month following the calendar month in which the Date of
Termination occurs. 

  
 Exh. A-1 

 EXHIBIT B 

CALCULATION OF CIC TERMINATION SEVERANCE AMOUNTS 
  

							
	 Severance Classification
	  	 Cash Severance
	  	 Equity Acceleration
	  	 COBRA

Period (1)

	Tier 1	  	24 months Base Salary + 2.0x Target Bonus	  	Full vesting acceleration of time-based Equity Awards.	  	18 months (2)
	Tier 2	  	12 months Base Salary + 1.0x Target Bonus	  	12 months

 (1) COBRA Period begins on the first day of the calendar month following the calendar month in which the Date of Termination
occurs. 
 (2) If COBRA is available for 24 months, then instead will refer to 24 months.     

  
 Exh. B-1 

 EXHIBIT C 

FORM OF RELEASE 
 1.
Release. For valuable consideration, including the payments or benefits under Section 4 of the Sonendo Inc. Executive Severance Plan (the “Severance Plan”), the receipt and adequacy of which are hereby
acknowledged, the undersigned does hereby release and forever discharge the “Releasees” hereunder, consisting of Sonendo Inc., a Delaware corporation (the “Company”), and the Company’s partners,
subsidiaries, associates, affiliates, successors, heirs, assigns, agents, directors, officers, employees, representatives, lawyers, insurers, and all persons acting by, through, under or in concert with them, or any of them, of and from any and all
manner of action or actions, cause or causes of action, in law or in equity, suits, debts, liens, contracts, agreements, promises, liability, claims, demands, damages, losses, costs, attorneys’ fees or expenses, of any nature whatsoever, known
or unknown, fixed or contingent (hereinafter called “Claims”), which the undersigned now has or may hereafter have against the Releasees, or any of them, by reason of any matter, cause, or thing whatsoever from the beginning
of time to the date hereof. The Claims released herein include, without limiting the generality of the foregoing, any Claims in any way arising out of, based upon, or related to the employment or termination of employment of the undersigned by
the Releasees, or any of them; any alleged breach of any express or implied contract of employment; any alleged torts or other alleged legal restrictions on Releasees’ right to terminate the employment of the undersigned; and any alleged
violation of any federal, state or local statute or ordinance including, without limitation, Title VII of the Civil Rights Act of 1964, the Age Discrimination In Employment Act, the Americans With Disabilities Act. 

2. Claims Not Released. Notwithstanding the foregoing, this general release (the “Release”) shall not operate to
release any rights or claims of the undersigned (i) to payments or benefits under Section 4 of the Severance Plan, with respect to the payments and benefits provided in exchange for this Release, (ii) to payments or benefits under any
equity award agreement between the undersigned and the Company, (iii) to accrued or vested benefits the undersigned may have, if any, as of the date hereof under any applicable plan, policy, practice, program, contract or agreement with the
Company, (iv) to any Claims, including claims for indemnification and/or advancement of expenses arising under any indemnification agreement between the undersigned and the Company or under the bylaws, certificate of incorporation or other
similar governing document of the Company, (v) to any Claims which cannot be waived by an employee under applicable law or (vi) with respect to the undersigned’s right to communicate directly with, cooperate with, or provide
information to, any federal, state or local government regulator. 
 3. Unknown Claims. 

THE UNDERSIGNED ACKNOWLEDGES THAT THE UNDERSIGNED HAS BEEN ADVISED BY LEGAL COUNSEL AND IS FAMILIAR WITH THE PROVISIONS OF CALIFORNIA CIVIL
CODE SECTION 1542, WHICH PROVIDES AS FOLLOWS: 
 “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR
RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.” 

  
 Exh. C-1 

 THE UNDERSIGNED, BEING AWARE OF SAID CODE SECTION, HEREBY EXPRESSLY WAIVES ANY RIGHTS THE UNDERSIGNED MAY
HAVE THEREUNDER, AS WELL AS UNDER ANY OTHER STATUTES OR COMMON LAW PRINCIPLES OF SIMILAR EFFECT. 
 4. Exceptions. Notwithstanding
anything in this Release to the contrary, nothing contained in this Release shall prohibit the undersigned from (i) filing a charge with, reporting possible violations of federal law or regulation to, participating in any investigation by, or
cooperating with any governmental agency or entity or making other disclosures that are protected under the whistleblower provisions of applicable law or regulation and/or (ii) communicating directly with, cooperating with, or providing
information (including trade secrets) in confidence to, any federal, state or local government regulator (including, but not limited to, the U.S. Securities and Exchange Commission, the U.S. Commodity Futures Trading Commission, or the U.S.
Department of Justice) for the purpose of reporting or investigating a suspected violation of law, or from providing such information to the undersigned’s attorney or in a sealed complaint or other document filed in a lawsuit or other
governmental proceeding. Pursuant to 18 USC Section 1833(b), the undersigned will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made: (x) in confidence to
a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (y) in a complaint or other document filed in a lawsuit
or other proceeding, if such filing is made under seal. 
 5. Representations. The undersigned represents and warrants that there has
been no assignment or other transfer of any interest in any Claim which the undersigned may have against Releasees, or any of them, and the undersigned agrees to indemnify and hold Releasees, and each of them, harmless from any liability, Claims,
demands, damages, costs, expenses and attorneys’ fees incurred by Releasees, or any of them, as the result of any such assignment or transfer or any rights or Claims under any such assignment or transfer. It is the intention of the parties
that this indemnity does not require payment as a condition precedent to recovery by the Releasees against the undersigned under this indemnity. 

6. No Action. The undersigned agrees that if the undersigned hereafter commences any suit arising out of, based upon, or relating to any
of the Claims released hereunder or in any manner asserts against Releasees, or any of them, any of the Claims released hereunder, then the undersigned agrees to pay to Releasees, and each of them, in addition to any other damages caused to
Releasees thereby, all attorneys’ fees incurred by Releasees in defending or otherwise responding to said suit or Claim. 
 7. No
Admission. The undersigned further understands and agrees that neither the payment of any sum of money nor the execution of this Release shall constitute or be construed as an admission of any liability whatsoever by the Releasees, or any of
them, who have consistently taken the position that they have no liability whatsoever to the undersigned. 
 8. OWBPA. The undersigned
agrees and acknowledges that this Release constitutes a knowing and voluntary waiver and release of all Claims the undersigned has or may have against the Company and/or any of the Releasees as set forth herein, including, but not limited to, all
Claims arising under the Older Worker’s Benefit Protection Act and the Age Discrimination in Employment Act. In accordance with the Older Worker’s Benefit Protection Act, the undersigned is hereby advised as follows: 

 

	 	(i)	 the undersigned has read the terms of this Release, and understands its terms and effects, including the fact
that the undersigned agreed to release and forever discharge the Company and each of the Releasees, from any Claims released in this Release; 

  
 Exh. C-2 

	 	(ii)	 the undersigned understands that, by entering into this Release, the undersigned does not waive any Claims that
may arise after the date of the undersigned’s execution of this Release, including without limitation any rights or claims that the undersigned may have to secure enforcement of the terms and conditions of this Release; 

 

	 	(iii)	 the undersigned has signed this Release voluntarily and knowingly in exchange for the consideration described
in this Release, which the undersigned acknowledges is adequate and satisfactory to the undersigned and which the undersigned acknowledges is in addition to any other benefits to which the undersigned is otherwise entitled; 

 

	 	(iv)	 the Company advises the undersigned to consult with an attorney prior to executing this Release;

  

	 	(v)	 the undersigned has been given at least [21]1 days in
which to review and consider this Release. To the extent that the undersigned chooses to sign this Release prior to the expiration of such period, the undersigned acknowledges that the undersigned has done so voluntarily, had sufficient time to
consider the Release, to consult with counsel and that the undersigned does not desire additional time and hereby waives the remainder of the [21]-day period; and 

 

	 	(vi)	 the undersigned may revoke this Release within seven days from the date the undersigned signs this Release and
this Release will become effective upon the expiration of that revocation period if the undersigned has not revoked this Release during such seven-day period. If the undersigned revokes this Release during
such seven-day period, this Release will be null and void and of no force or effect on either the Company or the undersigned and the undersigned will not be entitled to any of the payments or benefits which
are expressly conditioned upon the execution and non-revocation of this Release. Any revocation must be in writing and sent to [name], via electronic mail at [email address], on or before [11:59
p.m. Pacific time] on the seventh day after this Release is executed by the undersigned.]2 

9. Governing Law. This Release is deemed made and entered into in the State of California, and in all respects shall be interpreted,
enforced and governed under the internal laws of the State of California, to the extent not preempted by federal law. 
 IN WITNESS WHEREOF,
the undersigned has executed this Release this ____ day of ___________, ____. 
  

                       
                                         
                                   

[______] 
  

	1 	 NTD: Use 45 days in a group termination, and include information regarding terminated positions.

	2 	 NTD: Include if employee is at least 40 years old at the time of the termination. 

  
 Exh. C-3 

 EXHIBIT D 

DETAILED CLAIMS PROCEDURES 

Section 1.1. Claim Procedure. Claims for benefits under the Plan shall be administered in accordance with Section 503 of ERISA and the
Department of Labor Regulations thereunder. The Administrator shall have the right to delegate its duties under this Exhibit and all references to the Administrator shall be a reference to any such delegate, as well. The Administrator shall
make all determinations as to the rights of any Participant, beneficiary, alternate payee or other person who makes a claim for benefits under the Plan (each, a “Claimant”). A Claimant may authorize a representative to act on his or
her behalf with respect to any claim under the Plan. A Claimant who asserts a right to any benefit under the Plan he or she has not received, in whole or in part, must file a written claim with the Administrator. All written claims shall be
submitted to Legal@Sonendo.com. 
 (a) Regular Claims Procedure. The claims procedure in this subsection (a) shall apply to all
claims for Plan benefits. 
 (1) Timing of Denial. If the Administrator denies a claim in whole or in part (an “adverse
benefit determination”), then the Administrator will provide notice of the decision to the Claimant within a reasonable period of time, not to exceed 90 days after the Administrator receives the claim, unless the Administrator determines
that an extension of time for processing is required. In the event that the Administrator determines that such an extension is required, written notice of the extension will be furnished to the Claimant before the end of the initial 90 day review
period. The extension will not exceed a period of 90 days from the end of the initial 90 day period, and the extension notice will indicate the special circumstances requiring such extension of time and the date by which the Administrator expects to
render the benefit decision. 
 (2) Denial Notice. The Administrator shall provide every Claimant who is denied a claim for benefits
with a written or electronic notice of its decision. The notice will set forth, in a manner to be understood by the Claimant: 
  

	 	(i)	 the specific reason or reasons for the adverse benefit determination; 

 

	 	(ii)	 reference to the specific Plan provisions on which the determination is based; 

 

	 	(iii)	 a description of any additional material or information necessary for the Claimant to perfect the claim and an
explanation as to why such information is necessary; and 

  

	 	(iv)	 an explanation of the Plan’s appeal procedure and the time limits applicable to such procedures, including
a statement of the Claimant’s right to bring an action under Section 502(a) of ERISA after receiving a final adverse benefit determination upon appeal. 

(3) Appeal of Denial. The Claimant may appeal an initial adverse benefit determination by submitting a written appeal to the
Administrator within 60 days of receiving notice of the denial of the claim. The Claimant: 
  

	 	(i)	 may submit written comments, documents, records and other information relating to the claim for benefits;

	 	(ii)	 will be provided, upon request and without charge, reasonable access to and copies of all documents, records
and other information relevant to the Claimant’s claim for benefits; and 

  

	 	(iii)	 will receive a review that takes into account all comments, documents, records and other information submitted
by the Claimant relating to the appeal, without regard to whether such information was submitted or considered in the initial benefit determination. 

(4) Decision on Appeal. The Administrator will conduct a full and fair review of the claim and the initial adverse benefit
determination. The Administrator holds regularly scheduled meetings at least quarterly. The Administrator shall make a benefit determination no later than the date of the regularly scheduled meeting that immediately follows the Plan’s receipt
of an appeal request, unless the appeal request is filed within 30 days preceding the date of such meeting. In such case, a benefit determination may be made by no later than the date of the second regularly scheduled meeting following the
Plan’s receipt of the appeal request. If special circumstances require a further extension of time for processing, a benefit determination shall be rendered no later than the third regularly scheduled meeting of the Administrator following the
Plan’s receipt of the appeal request. If such an extension of time for review is required, the Administrator shall provide the Claimant with written notice of the extension, describing the special circumstances and the date as of which the
benefit determination will be made, prior to the commencement of the extension. The Administrator generally cannot extend the review period any further unless the Claimant voluntarily agrees to a longer extension. The Administrator shall notify the
Claimant of the benefit determination as soon as possible but not later than five days after it has been made. 
 (5) Notice of
Determination on Appeal. The Administrator shall provide the Claimant with written or electronic notification of its benefit determination on review. In the case of an adverse benefit determination, the notice shall set forth, in a manner
intended to be understood by the Claimant: 
  

	 	(i)	 the specific reason or reasons for the adverse benefit determination; 

 

	 	(ii)	 reference to the specific Plan provisions on which the adverse benefit determination is based;

  

	 	(iii)	 a statement that the Claimant is entitled to receive, upon request and without charge, reasonable access to,
and copies of, all documents, records and other information relevant to the claim for benefits; 

  

	 	(iv)	 a statement describing any voluntary appeal procedures offered by the Plan and the Claimant’s right to
obtain the information about such procedures; and 

  

	 	(v)	 a statement of the Claimant’s right to bring an action under Section 502(a) of ERISA.

 (b) Exhaustion; Judicial Proceedings. No action at law or in equity shall be brought to recover benefits under
the Plan until the claim and appeal rights described in the Plan have been exercised and the Plan benefits requested in such appeal have been denied in whole or in part. If any judicial proceeding is undertaken to appeal the denial of a claim or
bring any other action under ERISA other than a breach of fiduciary claim, the evidence presented may be strictly limited to the evidence timely presented to the Administrator. Any such judicial proceeding must be filed by the earlier of:
(a) one year after the 

 
Administrator’s final decision regarding the claim appeal or (b) one year after the Participant or other Claimant commenced payment of the Plan benefits at issue in the judicial
proceeding. The jurisdiction and venue for any judicial proceedings arising under or relating to the Plan will be exclusively in the courts in California, including the federal courts located there should federal jurisdiction exist. This paragraph
(c) shall not be construed to prohibit the enforcement of any arbitration agreements. 
 (c) Administrator’s Decision is
Binding. Benefits under the Plan shall be paid only if the Administrator decides in its sole discretion that a Claimant is entitled to them. In determining claims for benefits, the Administrator has the authority to interpret the Plan, to
resolve ambiguities, to make factual determinations, and to resolve questions relating to eligibility for and amount of benefits. Subject to applicable law, any decision made in accordance with the above claims procedures is final and binding on all
parties and shall be given the maximum possible deference allowed by law. A misstatement or other mistake of fact shall be corrected when it becomes known and the Administrator shall make such adjustment on account thereof as it considers equitable
and practicable.Exhibit 10.1

 

 

October 25, 2021

 

Edoc Acquisition Corp.

7612 Main Street Fishers

Suite 200

Victor, NY 14564

Attention: Kevin Chen

 

I-Bankers Securities
Inc.

535 5th Ave

Suite 423

New York, New York
10017

Attention: Mike McCrory

 

Dear Messrs. Chen and
McCrory:

 

Reference is made to the Letter
Agreement, dated November 9, 2020 (the “Letter Agreement”) by and among Edoc Acquisition Corp., a Cayman Islands
exempted company (the “Company”), American Physicians LLC (“Sponsor”) and the Insiders
(as defined in the Letter Agreement). The Letter Agreement was delivered to you in accordance with the Underwriting Agreement (the “Underwriting
Agreement”) entered into by and between the Company and I-Bankers Securities Inc., as Representative (the “Representative”)
of the several Underwriters named in Schedule A thereto (the “Underwriters”), relating to an underwritten initial
public offering (the “IPO”) of the Company’s units (the “Units”), each comprised
of one Class A ordinary share, $0.0001 par value per share, of the Company (the “Class A Ordinary Shares”) and
one redeemable warrant (the “Warrant”) to purchase one-half of one Class A Ordinary Share and one right to receive
one-tenth (1/10) of one Class A Ordinary Share upon the consummation of the Company’s initial business combination (the “Right”).
Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Letter Agreement.

 

The undersigned, Christine Zhao,
Chief Financial Officer of the Company, is an Insider and a signatory to the Letter Agreement. As you are aware, pursuant to Section 15
of the Letter Agreement, the undersigned agreed not to become involved with another publicly listed blank check company with a class of
securities registered under the Exchange Act prior to the Company announcing an agreement with an acquisition target for its initial Business
Combination, or the expiration of the period for the Company to announce and/or complete the Company’s initial Business Combination.
On January 5, 2021, the undersigned entered into a waiver letter to permit Ms. Zhao to serve as an independent director of one other publicly
listed blank check company, subject to certain conditions.

 

In view of the fact that the Registration
Statement permits Insiders to participate in other blank check companies, whether or not the Company has announced an agreement for its
initial Business Combination, the undersigned hereby requests that each of the Company and the Representative partially waive compliance
by the undersigned with Section 15 of the Letter Agreement, to enable the undersigned to serve as an independent director of a third publicly
listed blank check company prior to the completion of the Company’s initial Business Combination (the “Other Directorship”,
subject to the following conditions:

 

		(a)	Such other publicly listed blank check company shall focus on acquisition targets outside of the health
care and health care provider space in North America and Asia-Pacific;

 

		(b)	The undersigned agrees that, if she becomes aware of a business combination opportunity through her Other
Directorship that might be suitable to the Company’s business or investment strategy (a “Competitive Opportunity”),
she will recuse herself from all discussions, deliberations, or decisions of the other publicly listed blank check company with respect
to such Competitive Opportunity.

 

    

     

    

		(c)	On or prior to the date hereof, such publicly listed blank check company has submitted written acknowledgement
to each of the Company and the Representative that the undersigned’s entry into this letter and fulfillment of obligations herein
does and will not violate any of her contractual or fiduciary obligations to such company.

 

By signing the counterpart to
this letter, each of the Company and the Representative, for good and valuable consideration, the receipt and sufficiency of which is
hereby acknowledged, hereby (i) consents to the Other Directorship and waives in part the compliance by the undersigned with Section 15
of the Letter Agreement, and (ii) confirms and acknowledges that, subject to the satisfaction of the conditions stated herein, the Other
Directorship shall not constitute a breach of the Company’s covenant under Section 15 of the Letter Agreement. Except as specifically
waived herein, the Company retains all rights, and the undersigned retains all obligations, as set forth in the Letter Agreement, and
the Representative retains all rights as set forth in the Underwriting Agreement.

 

[Signature page follows]

 

    

     

    

 

 

If you are in agreement with the
foregoing, kindly indicate such agreement by signing the counterpart to this letter and returning the signed copy thereof to the Company
at the address first written above or by e-mail at kevin.chen@edocmed.net.

 

	 	Sincerely,
	 	 
	 	/s/ Christine Zhao
	 	Christine Zhao

 

 

	ACKNOWLEDGED AND AGREED TO:	 	 	 
	 	 	 	 
	EDOC ACQUISITION CORP.	 	 	 
	 	 	 	 	 
	By:	/s/ Kevin Chen	 	 	 
	Name: 	Kevin Chen	 	 	 
	Title:	Chief Executive Officer	 	 	 
	 	 	 	 	 
	Date: October 23, 2021	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	I-BANKERS SECURITIES INC.	 	 	 
	 	 	 	 	 
	By:	/s/ Mike McCrory	 	 	 
	Name: 	Mike McCrory	 	 	 
	Title:	Chief Executive Officer	 	 	 
	 	 	 	 	 
	Date: October 25, 2021

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]